By correcting disease‐causing mutations in RBM20 that disrupt its nuclear localization and splicing regulatory function, CRISPR strategies in DCM aim to restoring splicing of titin (TTN) and other sarcomeric genes [361, 362]. The gene discussed is TTN; the disease is familial dilated cardiomyopathy.